AAAAAA
Results: 1-25/45
Authors:
Kamphuisen, PW
Eikenboom, JCJ
Bertina, RM
Citation: Pw. Kamphuisen et al., Elevated factor VIII levels and the risk of thrombosis, ART THROM V, 21(5), 2001, pp. 731-738
Authors:
Bertina, RM
Citation: Rm. Bertina, Genetic approach to thrombophilia, THROMB HAEM, 86(1), 2001, pp. 92-103
Authors:
de Visser, MCH
Poort, SR
Vos, HL
Rosendaal, FR
Bertina, RM
Citation: Mch. De Visser et al., Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis, THROMB HAEM, 85(6), 2001, pp. 1011-1017
Authors:
Ceelie, H
Bertina, RM
Vlieg, AV
Rosendaal, FR
Vos, HL
Citation: H. Ceelie et al., Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels, THROMB HAEM, 85(6), 2001, pp. 1066-1070
Authors:
van den Besselaar, AMHP
van Dam, W
Sturk, A
Bertina, RM
Citation: Amhp. Van Den Besselaar et al., Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubes, THROMB HAEM, 85(4), 2001, pp. 647-650
Authors:
Bertina, RM
Citation: Rm. Bertina, Genetic aspects of venous thrombosis, EUR J OB GY, 95(2), 2001, pp. 189-192
Authors:
Bloemenkamp, KWM
de Groot, CJM
De Ronde, H
Duvekot, EJ
Helmerhorst, FM
Bertina, RM
Citation: Kwm. Bloemenkamp et al., The effect of factor V Leiden, oral contraceptive use: type of oral contraceptives and pregnancy on APC-r levels in women with or without a history of pre-eclampsia, EUR J OB GY, 95(2), 2001, pp. 225-225
Authors:
Hoibraaten, E
Mowinckel, MC
de Ronde, H
Bertina, RM
Sandset, PM
Citation: E. Hoibraaten et al., Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial, BR J HAEM, 115(2), 2001, pp. 415-420
Authors:
Kamphuisen, PW
Eikenboom, JCJ
Rosendaal, FR
Koster, T
Blann, AD
Vos, HL
Bertina, RM
Citation: Pw. Kamphuisen et al., High factor VIII antigen levels increase the risk of venous thrombosis butare not associated with polymorphisms in the von Willebrand factor and factor VIII gene, BR J HAEM, 115(1), 2001, pp. 156-158
Authors:
Lensen, R
Bertina, RM
Vandenbroucke, JP
Rosendaal, FR
Citation: R. Lensen et al., High factor VIII levels contribute to the thrombotic risk in families withfactor V Leiden, BR J HAEM, 114(2), 2001, pp. 380-386
Authors:
Garcia, EBG
Poort, SR
Stibbe, J
Sturk, A
Schaap, MCL
Kappers, M
Bertina, RM
Citation: Ebg. Garcia et al., Two novel and one recurrent missense mutation in the factor XIII A gene intwo Dutch patients with factor XIII deficiency, BR J HAEM, 112(2), 2001, pp. 513-518
Authors:
Brouwers, GJ
Vos, HL
Leebeek, FWG
Bulk, S
Schneider, M
Boffa, M
Koschinsky, M
van Tilburg, NH
Nesheim, ME
Bertina, RM
Garcia, EBG
Citation: Gj. Brouwers et al., A novel, possibly functional, single nucleotide polymorphism in the codingregion of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels, BLOOD, 98(6), 2001, pp. 1992-1993
Authors:
Kamphuisen, PW
Rosendaal, FR
Eikenboom, JCJ
Bos, R
Bertina, RM
Citation: Pw. Kamphuisen et al., Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels, ART THROM V, 20(5), 2000, pp. 1382-1386
Authors:
Doggen, CJM
de Visser, MCH
Vos, HL
Bertina, RM
Cats, VM
Rosendaal, FR
Citation: Cjm. Doggen et al., The HR2 haplotype of factor V is not associated with the risk of myocardial infarction, THROMB HAEM, 84(5), 2000, pp. 815-818
Authors:
Lensen, RPM
Bertina, RM
de Ronde, H
Vandenbroucke, JP
Rosendaal, FR
Citation: Rpm. Lensen et al., Venous thrombotic risk in family members of unselected individuals with factor V Leiden, THROMB HAEM, 83(6), 2000, pp. 817-821
Authors:
de Visser, MCH
Guasch, JF
Kamphuisen, PW
Vos, HL
Rosendaal, FR
Bertina, RM
Citation: Mch. De Visser et al., The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis, THROMB HAEM, 83(4), 2000, pp. 577-582
Authors:
Bertina, RM
Citation: Rm. Bertina, Protein C deficiency and venous thrombosis - the search for the second genetic defect, THROMB HAEM, 83(3), 2000, pp. 360-361
Authors:
Strijks, E
Poort, SR
Renier, WO
Gabreels, FJM
Bertina, RM
Citation: E. Strijks et al., Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy. (vol 30, pg 320, 1999), NEUROPEDIAT, 31(4), 2000, pp. 223-223
Authors:
Meijers, JCM
Tekelenburg, WLH
Bouma, BN
Bertina, RM
Rosendaal, FR
Citation: Jcm. Meijers et al., High levels of coagulation factor XI as a risk factor for venous thrombosis., N ENG J MED, 342(10), 2000, pp. 696-701
Authors:
Veltrop, MHAM
Bancsi, MJLMF
Bertina, RM
Thompson, J
Citation: Mham. Veltrop et al., Role of monocytes in experimental Staphylococcus aureus endocarditis, INFEC IMMUN, 68(8), 2000, pp. 4818-4821
Authors:
Doggen, CJM
Bertina, RM
Cats, VM
Rosendaal, FR
Citation: Cjm. Doggen et al., Fibrinogen polymorphisms are not associated with the risk of myocardial infarction, BR J HAEM, 110(4), 2000, pp. 935-938
Authors:
Kamphuisen, PW
Lensen, R
Houwing-Duistermaat, JJ
Eikenboom, JCJ
Harvey, M
Bertina, RM
Rosendaal, FR
Citation: Pw. Kamphuisen et al., Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia, BR J HAEM, 109(3), 2000, pp. 519-522
Authors:
van Tilburg, NH
Rosendaal, FR
Bertina, RM
Citation: Nh. Van Tilburg et al., Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis, BLOOD, 95(9), 2000, pp. 2855-2859
Authors:
Vlieg, AV
van der Linden, IK
Bertina, RM
Rosendaal, FR
Citation: Av. Vlieg et al., High levels of factor IX increase the risk of venous thrombosis, BLOOD, 95(12), 2000, pp. 3678-3682
Authors:
van den Eijnden, MMED
van Noort, JT
Hollaar, L
van der Laarse, A
Bertina, RM
Citation: Mmed. Van Den Eijnden et al., Cholesterol or triglyceride loading of human monocyte-derived macrophages by incubation with modified lipoproteins does not induce tissue factor expression, ART THROM V, 19(2), 1999, pp. 384-392